RenovoRx, Inc. Reports Results for Quarter Ended June 30, 2026

What Happened

• RenovoRx, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release dated August 12, 2026.
• The company filed Form 8‑K (Item 2.02) to disclose those results and incorporated the full text of the press release as Exhibit 99.1.

Key Details

• Filing date: August 12, 2026 (Form 8‑K, Item 2.02).
• Period covered: quarter ended June 30, 2026.
• Disclosure vehicle: press release attached as Exhibit 99.1 and incorporated by reference.
• The 8‑K notes the results of operations and financial condition were reported (see press release for full numerical details).

Why It Matters

• This 8‑K provides RenovoRx’s most recent quarterly earnings information, which investors use to assess near‑term financial performance (earnings, revenue, expenses) and operational progress.
• The filing itself does not include the numeric results in the 8‑K summary; retail investors should read the attached press release (Exhibit 99.1) and any subsequent SEC filings for the specific figures and management commentary before making investment decisions.